CFDE Data Portal | Search CELA3A

	Label	Description
	CELA3A associations Collection (Entity type)	Associations for CELA3A_associations
	CELA3A associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CELA3A Gene (Entity type)	ENSG00000142789 - chymotrypsin like elastase 3A
	KFGENEBIN:CELA3A-variant-count CUI gene has variants CELA3A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE193351 ruxolitinib 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228106 3 V 5 PACLITAXEL HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE158458 2 V 1 SORAFENIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE161897 MBNL knockout 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	KFGENEBIN:CELA3A-variant-count CUI Kfgenebin (Entity type)	A Kfgenebin
	GSE193351 1 V 2 RUXOLITINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

CELA3A associations

Associations for CELA3A_associations

CELA3A associations.tsv

A file from IDG as part of the Harmonizome project

CELA3A

ENSG00000142789 - chymotrypsin like elastase 3A

KFGENEBIN:CELA3A-variant-count CUI gene has variants CELA3A

A Knowledge Graph Assertion from Kids First

GSE193351 ruxolitinib 1 v 2 human dn

A Gene Set from LINCS

GSE228106 3 V 5 PACLITAXEL HUMAN DN

A Gene Set from LINCS

GSE158458 2 V 1 SORAFENIB HUMAN DN

A Gene Set from LINCS

GSE161897 MBNL knockout 2 v 1 human dn

A Gene Set from LINCS

KFGENEBIN:CELA3A-variant-count CUI

A Kfgenebin

GSE193351 1 V 2 RUXOLITINIB HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.